Back to search
FDAFDA · Food and drugs·Recall number D-318-2013

Liothyronine Sodium Tablets, USP, 5 mcg Rx ONLY, 100 count bottle, Distributed by: Paddock Laboratories, Inc., Minneapolis, MN 55427, NDC 0574-0220-01,

Published May 15, 2013 · Recall initiated: March 12, 2013

Summary

FDA records drug Class III recall D-318-2013, published May 15, 2013 and initiated March 12, 2013. Recalling firm: L. Perrigo Co.; Status: Terminated; Reported quantity: 21,667 bottles; Lot: 12K714 exp. 12/13, 12K715 exp. 12/13. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications: 3 month stability testing.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
L. Perrigo Co.
Distributor
Nationwide
Lot
12K714 exp. 12/13, 12K715 exp. 12/13
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Liothyronine Sodium Tablets, USP, 5 mcg Rx ONLY, 100 count bottle, Distributed by: Paddock Laboratories, Inc., Minneapolis, MN 55427, NDC 0574-0220-01, recalled?

Yes. FDA published recall D-318-2013 on May 15, 2013. Reported hazard: Failed Impurities/Degradation Specifications: 3 month stability testing.

What should I do if I have this product?

Voluntary: Firm initiated · Letter